MORRISTOWN, N.J.--(BUSINESS WIRE)--RxC International today announced that Richard J. Tinsley, MBA, MEd, has joined the firm as a senior partner. RxC International is a life sciences management consulting firm specializing in corporate strategy, new product development, and commercialization.
“We are delighted to announce that Rich has joined RxC International,” said RxC International Managing Partner Subbarao Jayanthi. “Rich’s tremendous expertise in the life sciences industry further enhances the RxC International team and helps to strengthen our presence in the Boston area. It’s an exciting time for us to have Rich on board as we continue to expand our business.”
Tinsley brings more than 20 years of strategy consulting experience in the life sciences industry to his role as a senior partner with RxC International. Prior to joining RxC International, Tinsley consulted for several leading life science companies, successfully crafting and implementing corporate, commercialization, and life cycle management strategies. Tinsley recently served on the board of directors of the Massachusetts Board of Registration in Pharmacy, and he has previously held leadership roles at Bain & Company and Putnam Associates. Tinsley holds an undergraduate degree in finance from Wharton at University of Pennsylvania and an MBA from Stanford University.
About RxC International
RxC International is a life sciences management consulting firm specializing in corporate strategy, new product development, and commercialization. RxC International brings strategic and operational expertise to its clients via a unique consulting delivery model that delivers exceptional value. RxC International clients include leading pharmaceutical and biotechnology companies as well as specialty life sciences companies such as vaccines, biosimilars, medical devices, etc. Based in Morristown, New Jersey, RxC International services clients all over the world. Additional information about RxC International can be found at www.RxCInternational.com.
